Literature DB >> 15478161

Patient-reported health care utilization in rheumatoid arthritis: what level of detail is required?

Jörg Ruof1, Jan L Huelsemann, Thomas Mittendorf, Silke Handelmann, J Matthias von der Schulenburg, Henning Zeidler, Rick Aultman, Sonja Merkesdal.   

Abstract

OBJECTIVE: To investigate the level of detail required in self-reported health care utilization questionnaires for administration to patients with rheumatoid arthritis (RA).
METHODS: A preliminary questionnaire was developed on the basis of existing tools for use in rheumatic conditions and in-depth interviews with 10 RA patients. Data gathered over 1 year of administration in a clinical setting were then matched to a comprehensive database of payer-reported information. Kappa statistics were calculated for each health care utilization domain. For domains where disaggregation into metric data was potentially preferable, histograms of difference were assessed visually and the strength of association examined using Spearman's rank correlation coefficient.
RESULTS: Patients (n = 136) included in the base case analysis determined the preferred levels of detail for each domain. Physician visits: occurrence of physician visits (yes/no; kappa not applicable) and their number (r = 0.42, P < 0.001). Medication use of the following drug classes (yes/no): disease-modifying antirheumatic drug (DMARD; kappa = 0.68), nonsteroidal antiinflammatory drug (kappa = 0.64), osteoporosis medication (kappa = 0.56), analgesic (kappa = 0.38), and steroid (kappa = 0.83). Further disaggregation into different DMARD classes was recommended (kappa ranging between 1 [use of biologics: yes/no] and 0.67 [use of azathioprine: yes/no]. Imaging: imaging of bones and chest (yes/no; kappa = 0.20). Hospitalization: inpatient episodes (yes/no; kappa = 0.64) and number of inpatient days (r = 0.80, P < 0.001). Transport: costs incurred (yes/no; kappa = 0.13) and amount (r = 0.39, P < 0.001).
CONCLUSION: The use of highly aggregated items to assess health care utilization in RA is supported. Dichotomous assessment (yes/no) was the preferred level of detail for items in the domains covering medication and diagnostic procedures or tests. Metric data is appropriate in 3 areas: number of physician visits, number of inpatient days, and total expenditure on transportation.

Entities:  

Mesh:

Year:  2004        PMID: 15478161     DOI: 10.1002/art.20686

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  [Conceptual and methodological basics of cost assessments in rheumatology].

Authors:  J Ruof; J L Hülsemann; T Mittendorf; J-M von der Schulenburg; H Zeidler; S Merkesdal
Journal:  Z Rheumatol       Date:  2004-10       Impact factor: 1.372

2.  Direct costs related to rheumatoid arthritis: the patient perspective.

Authors:  J L Hülsemann; T Mittendorf; S Merkesdal; S Handelmann; J-M von der Schulenburg; H Zeidler; J Ruof
Journal:  Ann Rheum Dis       Date:  2005-03-30       Impact factor: 19.103

3.  Costs in rheumatology: results and lessons learned from the 'Hannover Costing Study'.

Authors:  J L Hülsemann; J Ruof; H Zeidler; T Mittendorf
Journal:  Rheumatol Int       Date:  2005-11-01       Impact factor: 2.631

4.  Productivity loss as a major component of disease-related costs in patients with hypercholesterolemia in Germany.

Authors:  Jacqueline Müller-Nordhorn; Heike Englert; Karl Wegscheider; Hendrike Berger; Frank Sonntag; Heinz Völler; Wolfgang Meyer-Sabellek; Thomas Reinhold; Eberhard Windler; Hugo A Katus; Stefan N Willich
Journal:  Clin Res Cardiol       Date:  2007-12-01       Impact factor: 5.460

5.  [Current status and perspectives of ambulatory rheumatologic health care in Germany : economic structural conditions and motivation of rheumatologists].

Authors:  T Mittendorf; E Edelmann; J Kekow; U von Hinüber; W Müller-Brodmann; J-M Graf von der Schulenburg
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

6.  Good agreement between questionnaire and administrative databases for health care use and costs in patients with osteoarthritis.

Authors:  Daniel Pinto; M Clare Robertson; Paul Hansen; J Haxby Abbott
Journal:  BMC Med Res Methodol       Date:  2011-04-13       Impact factor: 4.615

7.  Development of a brief, generic, modular resource-use measure (ModRUM): cognitive interviews with patients.

Authors:  Kirsty Garfield; Samantha Husbands; Joanna C Thorn; Sian Noble; Will Hollingworth
Journal:  BMC Health Serv Res       Date:  2021-04-21       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.